Form 4: CONMED Corp Director John L. Workman Reports Transaction in Common Stock

Director John L. Workman reports a transaction involving CONMED Corp common stock and Restricted Stock Units (RSUs) on May 20, 2025.

Summary

• On May 20, 2025, John L. Workman, a director of CONMED Corp, reported a transaction involving the company's common stock.
• Workman acquired 479 shares of common stock at a price of $59.84.
• Following the transaction, Workman directly owns 20,891 shares of CONMED Corp common stock.
• The transaction also involved Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock.
• Thomas Fistek, acting as attorney-in-fact for John L. Workman, signed the report.
• A power of attorney document was filed, granting certain individuals the authority to execute filings on behalf of John Workman.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

This is a routine disclosure related to insider transactions, which are common and regulated to ensure transparency and prevent insider trading.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates

Keywords

Form 4, CONMED Corp, John L. Workman, Director, Common Stock, RSU, Restricted Stock Units, Beneficial Ownership, Transaction